Close
NOTICE: StreetInsider.com will be undergoing maintenance on Saturday, June 8th, from 11 AM to 10 PM EDT, and will be temporarily inaccessible.
Jun 7, 2024 12:32PM
Jun 7, 2024 12:00PM
Jun 7, 2024 10:32AM
Jun 7, 2024 10:31AM
Jun 7, 2024 09:00AM
Jun 7, 2024 08:56AM
Jun 7, 2024 08:35AM ChromaDex (CDXC) Receives Exclusive U.S. FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia
Jun 7, 2024 08:16AM
Jun 7, 2024 08:05AM
Jun 7, 2024 08:03AM
Jun 7, 2024 07:08AM
Jun 7, 2024 06:34AM
Jun 6, 2024 09:59PM
Jun 6, 2024 04:16PM Qiagen (QGEN) to discontinue NeuMoDx integrated PCR testing system
Jun 6, 2024 04:06PM
Jun 6, 2024 03:57PM
Jun 6, 2024 02:57PM
Jun 6, 2024 01:43PM
Jun 6, 2024 12:15PM
Jun 6, 2024 09:59AM
Jun 6, 2024 09:18AM Eli Lilly & Co. (LLY) on Watch After FDA Posts Documents Ahead of Panel Meeting for AD Drug
Jun 6, 2024 09:03AM
Jun 6, 2024 09:01AM
Jun 6, 2024 08:45AM
Jun 6, 2024 08:04AM
Jun 6, 2024 08:01AM
Jun 6, 2024 07:58AM
Jun 6, 2024 07:22AM Moderna's (MRNA) mRNA-3705 Selected by the FDA for START Pilot Program
Jun 6, 2024 07:16AM
Jun 6, 2024 07:13AM
Jun 6, 2024 05:43AM
Jun 5, 2024 04:08PM
Jun 5, 2024 04:02PM
Jun 5, 2024 09:05AM
Jun 5, 2024 09:01AM Amgen (AMGN) Reports Positive Phase 3 Results for UPLIZNA
Jun 5, 2024 08:55AM
Jun 5, 2024 08:31AM
Jun 5, 2024 08:30AM
Jun 5, 2024 08:30AM
Jun 5, 2024 08:06AM
Jun 5, 2024 07:01AM
Jun 5, 2024 07:01AM I-Mab Biopharma (IMAB) Collaborates with Bristol Myers Squibb (BMY) to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
Jun 5, 2024 07:00AM
Jun 5, 2024 07:00AM
Jun 5, 2024 07:00AM
Jun 5, 2024 06:02AM
Jun 5, 2024 06:00AM
Jun 5, 2024 05:46AM
Jun 5, 2024 05:23AM Gilead Sciences' (GILD) Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis
Jun 4, 2024 01:03PM

67,340 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.